Etoposide Oral Capsule

Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Mylan Pharmaceuticals Inc. (2013-07-22)
Oldest Current Product
2001-10-22
License(s)
ANDA
RxNORM
ORAL CAPSULE\ETOPOSIDE
FDAOB
ORAL\CAPSULE\ETOPOSIDE
SPL Active
ORAL\CAPSULE\ETOPOSIDE
SPL Moiety
ORAL\CAPSULE\ETOPOSIDE

product(s) by strength(s)

etoposide 50 mg oral capsule

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1003783266ANDAMylan Pharmaceuticals Inc.2001-10-22ETOPOSIDEORALCAPSULEANDA075635508a418e-985f-4208-9324-2230655bb5c2

application(s)

#idtitledeprecatedapplicantapprovedapproved drug
1ANDA075635ETOPOSIDEMYLAN PHARMACEUTICALS INC2001-09-19ANDA075635_001
2NDA019557VEPESIDTrueDAVA PHARMACEUTICALS INC1986-12-30NDA019557_001, NDA019557_002

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1ANDA075635_001RXETOPOSIDE (50MG)ORALCAPSULETrue2001-09-19ETOPOSIDE
2NDA019557_001discontinuedETOPOSIDE (50MG)ORALCAPSULEFalse1986-12-30VEPESID
3NDA019557_002discontinuedETOPOSIDE (100MG)ORALCAPSULEFalse1986-12-30VEPESID

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
1508a418e-985f-4208-9324-2230655bb5c2 (view SPL)prescriptionHuman PrescriptionMylan Pharmaceuticals Inc.2013-07-225003783266

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII